Compound 3a, also endowed with moderate activity against AChE/BChE, is a hit deserving further pharmacological studies, as a possible remedy in early symptoms of PD [27] and/or as an anti-oxidative neuroprotectant in AD patients [28]. The gene discussed is BCHE; the disease is Parkinson disease.